Radiolabelled Monoclonal Antibodies in Oncology. II. Clinical Applications in Diagnosis

Overview

Journal Nucl Med Commun

Specialty Nuclear Medicine

Date 1991 Feb 1

PMID 2002966

Citations 5

Authors

M Granowska

K E Britton

Affiliations

Soon will be listed here.

Abstract

The clinical applications of this approach to the management of patients with ovarian cancer and of patients with colorectal cancer are emphasized. The introduction of stable 99Tcm labelling of monoclonal antibodies means that radioimmunoscintigraphy is able to become routinely available in nuclear medicine departments.

Citing Articles

Radioimmunoscintigraphy with technetium-99m-labelled monoclonal antibody, SM3, in gynaecological cancer.

Granowska M, Britton K, Mather S, Lowe D, Ellison D, Bomanji J Eur J Nucl Med. 1993; 20(6):483-9.

PMID: 8339731 DOI: 10.1007/BF00175160.

Evaluation of a technique for the intraoperative detection of a radiolabelled monoclonal antibody against colorectal cancer.

Waddington W, Davidson B, Todd-Pokropek A, Boulos P, Short M Eur J Nucl Med. 1991; 18(12):964-72.

PMID: 1778208 DOI: 10.1007/BF00180417.

Does immunoscintigraphy serve clinical needs effectively? Is there a future for radioimmunotherapy?.

Chatal J, Peltier P, Bardies M, Chetanneau A, Thedrez P, Faivre-Chauvet A Eur J Nucl Med. 1992; 19(3):205-13.

PMID: 1572386 DOI: 10.1007/BF00173283.

Superimposition of computed tomography and single photon emission tomography immunoscintigraphic images in the pelvis: validation in patients with colorectal or ovarian carcinoma recurrence.

Liehn J, Loboguerrero A, PERAULT C, Demange L Eur J Nucl Med. 1992; 19(3):186-94.

PMID: 1572383 DOI: 10.1007/BF00173280.

Nuclear medicine.

Ell P Postgrad Med J. 1992; 68(796):82-105.

PMID: 1570267 PMC: 2399229. DOI: 10.1136/pgmj.68.796.82.